Journal
JOURNAL OF NERVOUS AND MENTAL DISEASE
Volume 198, Issue 10, Pages 748-754Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/NMD.0b013e3181f4aeac
Keywords
Depression; suicide; suicide risk; South Korea; CRESCEND
Categories
Funding
- Ministry of Health and Welfare, Republic of Korea [A050047]
- Korean branches of GlaxoSmithKline
- Janssen
- Eli Lilly
- Korean branches of Janssen
- AstraZeneca
- Korean branches of Otsuka
- Korean branches of AstraZeneca
- Pfizer
- Sanofi-Aventis
- Otsuka
- Organon
- GlaxoSmithKline
- Eisai
- Lundbeck
- Bukwang
- Whanin Pharma Co. Ltd.
Ask authors/readers for more resources
South Korea is a country with one of the highest suicide rates in the world, and the suicide rate is still on the rise. The purpose of this study was to determine the sociodemographic and clinical characteristics of suicide attempts and risk factors related to suicide attempts among depressed patients in South Korea. Among the 1183 participants, 21.4% had a history of a suicide attempt. When the severity of depression was controlled, the risk factors for patients who attempted suicide included younger age, experienced significant life events before 12 years of age, psychotic symptoms, and previous depressive episodes. The characteristics of attempted suicide in depressed patients in South Korea can be summarized as a high suicide attempt rate with no difference in the number of suicide attempts and lethality between males and females. This unique tendency is probably related to the sociodemographic and cultural characteristics of South Korea.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available